Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2020 07:30 ET | Source: OpGen, Inc.

Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumonia

Significant number of de-escalations (65.9%) could be made with high degree of clinical confidence when MRSA or Pseudomonas aeruginosa is not detected by the LRT PanelUnyvero LRT Panel had...
August 20, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19

- Own developed SARS-CoV-2 Kit with PULB for COVID-19 uses real-time PCR (RT-PCR) technology on open PCR platforms, designed to provide results in approximately one hour - 100% Sensitivity and...
August 12, 2020 16:05 ET | Source: OpGen, Inc.

OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update

Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020Strategic co-promotion partnership with Menarini...
August 11, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

Accurate identification of antibiotic resistance markers based on the ARESdb QIAGEN CLC Module leveraging Ares Genetics’ proprietary antibiotic resistance database Pathogens correctly identified with...
August 09, 2020 16:15 ET | Source: OpGen, Inc.

OpGen Co-Markets COVID-19 Antibody Test Kit

GAITHERSBURG, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) -- As disclosed in OpGen, Inc.’s (NASDAQ: OPGN) (“OpGen” or “the Company”) July 13, 2020 press release, we have commenced marketing and promotion,...
August 05, 2020 07:30 ET | Source: OpGen, Inc.

OpGen to Provide Business Update and Financial Results for the Second Quarter 2020

GAITHERSBURG, Md., Aug. 05, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second...
July 15, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2020

Preliminary Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 2020 GAITHERSBURG, Md., July 15, 2020 (GLOBE...
July 13, 2020 07:30 ET | Source: OpGen, Inc.

Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular...
July 09, 2020 11:59 ET | Source: OpGen, Inc.

OpGen Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non-Dilutive Debt Financing Tranche from EIB

- European Investment Bank (EIB) and OpGen, Curetis GmbH and Ares Genetics GmbH enter into Amendment to the EIB Financing Agreement - Additional EUR 5 Million Tranche With 5-Year Interest Only...
June 09, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19 Patients in Just Five Hours

Performance of the Unyvero HPN Panel for pneumonia proves to be strongly concordant (98.2%) compared to bacterial lower respiratory tract culture Collaboration with Karolinska Institutet highlights...